Compare Old Dominion Freight Line Inc (ODFL) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Old Dominion Freight Line Inc vs Twist Bioscience Corp — how do they compare? Old Dominion Freight Line Inc trades at $183.23 (market cap $36.42B), while Twist Bioscience Corp trades at $157.83 (market cap $10.32B). The key difference: Old Dominion Freight Line Inc is far larger — about 3.5× Twist Bioscience Corp's market cap, and Old Dominion Freight Line Inc pays a 0.66% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Old Dominion Freight Line Inc for 76 Days and Twist Bioscience Corp for 27 Days on average.
| ODFL | TWST | |
|---|---|---|
Market Cap | $36.42B | $10.32B |
Volume | 1,668,932 | 5,894,998 |
Sector | Industrials | Health |
52-Week High | $248.73 | $205.00 |
52-Week Low | $126.29 | $25.45 |
Typical Hold Time | 76 Days | 27 Days |
Enterprise Value | $36.15B | $10.24B |
Dividend Yield | 0.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Old Dominion Freight Line (ODFL) trades at $181.65, up 2.04% today, with a bearish technical signal despite recent earnings beats. The company maintains strong profitability with 19.44% net margins and 24.82% ROE, though revenue declined to $5.5B in 2025. Recent news highlights a 4.9% general rate increase effective October 5, 2026, aimed at offsetting operating costs while supporting service investments.
ODFL presents a mixed outlook with Wall Street's $230.93 consensus target suggesting 27% upside, yet technical indicators remain bearish. The stock's premium valuation (P/E 33.77) requires sustained earnings growth, while competitive pressures and freight demand volatility pose risks. Institutional buying and oversold technical conditions may support near-term recovery potential.
TWST trades at $152.05, down 8.94% over 24 hours, with a bearish technical signal and negative cash flows. Revenue growth is strong, reaching $376.57 million in 2025, but profitability remains elusive with a net income margin of -31.66%. Recent news highlights a partnership with Lilly TuneLab for AI-driven drug discovery, providing a potential growth catalyst amid ongoing losses.
The outlook is mixed; analyst consensus is bullish with a $145.20 price target, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on the company's ability to monetize its AI collaborations and achieve profitability, while downside risks include cash burn and competitive pressures in the biotech sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Old Dominion Freight Line Inc
Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
